Clinical Trial Results:
A 30-day, randomized, evalUator-blind, controlled, multi-centre, parallel Group, phase III study to evaluate the Effect of a Low Maintenance Dose TicAgrelor Regimen versus Standard Dose Clopidogrel on Coronary Flow Reserve in Diabetes Mellitus Patients with impaired microvascular function without Prior Myocardial Infarction or Stroke Undergoing Elective Percutaneous Coronary Intervention
Summary
|
|
EudraCT number |
2019-002226-79 |
Trial protocol |
SE IT |
Global completion date |
|
Paediatric regulatory details
|
|
Is the trial part of an agreed EMA paediatric investigation plan? |
|
Is the trial in scope of article 45 of Regulation (EC) No 1901/2006? |
|
Is the trial in scope of article 46 of Regulation (EC) No 1901/2006? |
|
Results information
|
|
Results version number |
v1(current) |
This version publication date |
15 Sep 2021
|
First version publication date |
15 Sep 2021
|
Other versions |
|
Summary report(s) |
AUGEAS Reason early termination and missing results_2021.08.18 |
Note: The legislation allows summary attachments to be posted instead of the full dataset for this trial. Refer to Commission Guideline 2012/C 302/03
for further information.